Go forward from 2019 to now and review what is known on Nader and Cydy.
Sabotaged HIV BLA submission
FDA rebuke
Unjust enrichment
RTF on HIV BLA
Sabotaged CD12 trial
3 failed CoVID trials
Lost arbitration to Pestell
No oversight on CRO for years.
SEC and DOJ investigations
Litigation with CRO
Class action suits
Insider trading
None of those issues were apparent in 2019. They are now.
Based on the Lack of performance in trials and the above, we will see if Cydy can attract any funding that does not ALLOW THE IMMEDIATE SALES OF SHARES INTO THE MARKET!
These investors are paying $.75 to $1.00 And IMMEDIATELY reselling at $1.20 to $1.30. That is not financing, that is loan sparking. Any idiot can attract money with those terms as long as the raises are small.
These private raises are BY DEFINITION SHOWING NO CONFIDENCE IN CYDY AS AN OPERATING BUSINESS. These investors are not taking any risk.
These investors buy shares and warrants at a 25 to 30% discount and can then sell immediately at market.
This practice has caused a continual erosion of the SP over the past 3 months and that has been micro raises.
When the tens of millions that need to raised are trying to be raised, we will see what happens to the SP… now that is a near term catalyst.
This dumping private placement shares immediately into the market is not sustainable.
News 
Market Data 
Discover 
